3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4
Vitamin D Deficiency
3
Prostatic Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Triple Negative Breast Neoplasms
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Psoriasis
1
Osteoporosis Secondary
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Immunoblastic Lymphadenopathy
1
Fractures, Stress
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Adenocarcinoma
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Intraductal, Noninfiltrating
1
Bone Metabolism Biomarkers
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
deucravacitinib
1
cabozantinib
1
Vitamin D
1
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Platinum Compounds
1
Nivolumab
1
Methods
1
Ipilimumab
1
Interviews as Topic
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Educational Status
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Psoriasis
×
Cholecalciferol
×
1 year
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts